Vertex Pharmaceuticals’ Post

At the American Society of Hematology Annual Meeting, we presented data from the AGAVE-201 study on the dynamics of clinical responses in patients with chronic graft-versus-host disease (GVHD) treated with a CSF-1R directed antibody. Learn more about these data by visiting our website. #ASH24 https://bit.ly/3VlMCZp

Significant Growth in #HCT Use for #Haemoglobinopathies in the Last Decade Driven By #Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of The EBMT Haemoglobinopathies Working Party #ASH24 American Society of Hematology

#LegendNews: We are excited to present new findings from our Phase 3 study at this year’s American Society of Hematology (ASH) Annual Meeting & Exposition. This latest data on minimal residual disease (MRD) negativity rates reinforces the strength of our research for those with #MultipleMyeloma. Learn more: https://bit.ly/3BmRJSw #ASH24 #CART

We're wrapping up an incredible few days at ASH! Last night, Canopy’s Lavi Kwiatkowsky and Andrew Frank joined Dr. Ben Derman to share findings on the use of ePRO-based Remote Therapeutic Monitoring by patients receiving bispecific antibodies and triplet therapies for relapsed/refractory multiple myeloma. Key insights include: - Increased symptom communication: At 30 days post-treatment, 45% of patients actively monitored had communicated their symptoms, compared to those using phone-based reporting (12.9%) - Improved detection of high-risk toxicities: Patients monitored via Canopy had critical symptoms identified at higher frequencies than phone-based reporting 👉 Learn more here: https://lnkd.in/evY6YvwD Thank you to our partners in community oncology for your collaboration and to the American Society of Hematology for an excellent program. #ASH24 #ASH2024

Wow! CRC Liver Metastases Cohort: Phase II of RO7198457 in Patients With ctDNA-positive, Resected Stage IV Colorectal Cancer Liver Metastases #CRCSM #colorectalcancer #livermets #vaccine

📰 EHA Guidelines create and provide clinical practice recommendations for the diagnosis and treatment of hematologic diseases. These are based on the best available evidence and expert consensus that can support the appropriate choice of diagnostic procedures and/or therapeutic interventions in the field of hematology. This week we highlight a recent joint EHA – ESMO guidelines publication on HIV-associated lymphomas 👉https://bit.ly/3zg0Gfc

🎧 Catch the latest episode of the the Uromigos (Brian Rini, MD, FASCO, Tom Powles, MBBS, MRCP, MD) with Daniel Goldstein, MD, on dosing issues and dosing changes in drugs such as #nivolumab and #pembrolizumab, as well as other immune checkpoint inhibitors. 👂 Listen Here:

Hamid R. Erfanian, Vice President and General Manager, Protein Diagnostics, Thermo Fisher Scientific commented on the announcement of our extended 510k Clearance of Freelite Assays for the evaluation of MGUS, a precursor to Multiple Myeloma, a blood cancer of plasma cells and the second most common hematologic malignancy in the U.S. “Our easy-to-use Freelite assays are trusted by healthcare professionals globally, and with the new claim, and as a key part of laboratory diagnostics tools, we can help healthcare providers continually evaluate patients with MGUS, which is important to understand the disorder and the progression to pathological malignancies” “Earlier identification of MGUS will enable more effective monitoring of disease progression and need for treatment, ultimately improving patient outcomes.” Read more here: https://hubs.li/Q02JlsnP0

The blood cells of a type 2 diabetic after consuming Kangen water. Before, the cells are all clumped together. After, the cells are flowing freely. Molecular hydrogen water is helping the diabetic blood cells by acting as a potent antioxidant, reducing oxidative stress within the cells, which is a key factor in diabetic complications. It has the potential to improve insulin sensitivity, decrease blood glucose levels, and protect against damage to blood vessel lining by mitigating inflammation, all due to its ability to easily penetrate cell membranes and interact with cellular pathways. Did you know is that the water ionizer I distribute is medically certified in Japan and has been used in their hospitals for over 50 years? Did you know they use this water as part of their regimen for cancer patients at Hope 4 Cancer in Mexico? Drop me a 💧 so I can share the Doctors on Kangen resource with you. [Kangen water, hydrogen water, electrolyzed reduced water, negative ions, water snob]

💫 #ONCOnews 💫 🌟 FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer 👉 The recommended ensartinib dose is 225 mg orally once daily, with or without food, until disease progression or unacceptable toxicity. 🔗 https://buff.ly/3ZLZ7PC #OncEd #OncoAlert